JohnClarkLucasMD

Physician

Are you Dr. Lucas?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 44 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. John Lucas, MD is a family physician in Kensington, Maryland. He is currently licensed to practice medicine in Maryland, District of Columbia, and Virginia. He is affiliated with Holy Cross Hospital.

PubMed

Stereoselective synthesis of cis-1,3-disubstituted cyclobutyl kinase inhibitors.
Helal, C.J., Kang, Z., Lucas, J.C., Bohall, B.R.> ;Org Lett. 2004 May 27
A concise and regioselective synthesis of 1-alkyl-4-imidazolecarboxylates.
Helal, C.J., Lucas, J.C.> ;Org Lett. 2002 Nov 14
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer''s disease.
Helal, C. J., Kang, Z., Lucas, J. C., Gant, T., Ahlijanian, M. K., Schachter, J. B., Richter, K. E., Cook, J. M., Menniti, F. S., Kelly, K., Mente, S., Pandit, J., Hos...> ;Bioorg Med Chem Lett. 2009 Oct 01
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer''s disease.
Helal, C. J., Sanner, M. A., Cooper, C. B., Gant, T., Adam, M., Lucas, J. C., Kang, Z., Kupchinsky, S., Ahlijanian, M. K., Tate, B., Menniti, F. S., Kelly, K., Peterso...> ;Bioorg Med Chem Lett. 2004 Nov 15
Join now to see all